Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Nowa Sol – page 5

83 clinical trials in Nowa Sol, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Nowa Sol at a glance
83
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

83 trials in Nowa Sol

Open in trial search

Systemic scleroderma

Not recruiting

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Fipaxalparant
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Study on BHV-7000 for Patients with Generalized Tonic-clonic Seizures in Idiopathic Generalized Epilepsy

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:BHV-7000
  • Sponsor:Biohaven Therapeutics Ltd.

Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.

Study on the Effects of Astegolimab and Drug Combination for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Genentech Inc.

Rheumatoid arthritis

Not recruiting

Study on the Effectiveness and Safety of Abatacept Biosimilar (DRL_AB) and Methotrexate for Patients with Moderate to Severe Rheumatoid Arthritis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Dr Reddy's Laboratories Limited

Psoriatic arthropathy

Not recruiting

Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International

Study of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Anifrolumab
  • Sponsor:AstraZeneca AB

Study on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Quinidine Sulfate
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Systemic scleroderma

Not recruiting

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Fipaxalparant
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Back pain

Not recruiting

Study on the Effects of VER-01, Ibuprofen, and Paracetamol for Patients with Chronic Non-Specific Low Back Pain

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dronabinol
  • Sponsor:Vertanical GmbH

Study on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.

Psoriatic arthropathy

Not recruiting

Study on the Effectiveness and Safety of Bimekizumab and Risankizumab in Adults with Active Psoriatic Arthritis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bimekizumab
  • Sponsor:UCB Biopharma

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Nowa Sol

What the registry says about research in the country

01 Rheumatology Studies

Innovative research focusing on psoriatic arthritis and rheumatoid arthritis treatments, evaluating new biological therapies and biosimilars for improved patient outcomes.

  • Zasocitinib for psoriatic arthritis
  • Tocilizumab biosimilar studies
  • Rosnilimab efficacy trials

Multiple studies are investigating novel therapeutic approaches for patients who haven't responded to conventional treatments.

02 Dermatological Conditions

Comprehensive research into atopic dermatitis and plaque psoriasis, including studies for both adult and pediatric populations.

  • Bimekizumab for plaque psoriasis
  • Lunsekimig for atopic dermatitis
  • ADX-914 clinical evaluation

These trials aim to advance treatment options for moderate to severe skin conditions.

03 Autoimmune Disorders

Groundbreaking research in Sjögren's Syndrome and systemic lupus erythematosus, testing novel therapeutic approaches.

  • Dazodalibep safety studies
  • Anifrolumab subcutaneous administration
  • Systemic sclerosis treatments

Focus on developing targeted therapies for complex autoimmune conditions.

04 Neurological Research

Studies addressing epilepsy and Alzheimer's-related conditions, including innovative treatment approaches for seizure management.

  • XEN1101 for seizure control
  • Alzheimer's agitation treatment
  • Staccato alprazolam evaluation

Research aims to improve quality of life for patients with neurological disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.